SCHEMBL6436601

SCHEMBL6436601

N#Cc1cccc(CNC(=O)c2cc3c(O)cccc3n2Cc2cccc(C#N)c2)c1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.67
F2 P00734 5/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6438689 0.95 F10 (0.63) F10F2
SCHEMBL6432935 0.85 CCR2 (0.64) F10F2
SCHEMBL6435685 0.82 F10 (0.71) F10F2
SCHEMBL6436698 0.82 F10 (0.66) F10F2
SCHEMBL6433022 0.81 F10 (0.65) F10F2
SCHEMBL6436710 0.80 F10 (0.55) F10F2
SCHEMBL6432496 0.80 F10 (0.62) F10F2
SCHEMBL6437276 0.80 F10 (0.81) F10F2
SCHEMBL6436384 0.80 F10 (0.54) F10F2
Iodide SCHEMBL6434334 0.79 F10 (0.63) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042287-B1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA AVENTIS PHARMA GMBH (DE) 2005-04-20 EP disclosed
US-6337344-B1 ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-08 US disclosed
EP-1042287-A1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA Aventis Pharma Deutschland GmbH (DE) 2000-10-11 EP disclosed
WO-1999033800-A1 INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-08 WO disclosed